Erin Wright
Stock Analyst at Morgan Stanley
(4.44)
# 291
Out of 4,941 analysts
234
Total ratings
62.21%
Success rate
13.34%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Equal-Weight | $16 → $17 | $20.89 | -18.62% | 9 | Aug 1, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $82 | $65.51 | +25.17% | 5 | Aug 1, 2025 | |
| HUM Humana | Maintains: Equal-Weight | $290 → $277 | $274.94 | +0.75% | 4 | Jul 31, 2025 | |
| ALGN Align Technology | Downgrades: Equal-Weight | $249 → $154 | $140.49 | +9.62% | 23 | Jul 31, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $428 → $316 | $292.48 | +8.04% | 3 | Jul 18, 2025 | |
| MCK McKesson | Maintains: Overweight | $770 → $810 | $659.01 | +22.91% | 8 | Jul 16, 2025 | |
| PSX Phillips 66 | Maintains: Equal-Weight | $122 → $128 | $120.04 | +6.63% | 1 | Jul 16, 2025 | |
| COR Cencora | Maintains: Equal-Weight | $313 → $330 | $289.15 | +14.13% | 1 | Jul 16, 2025 | |
| CAH Cardinal Health | Maintains: Overweight | $181 → $190 | $146.30 | +29.87% | 12 | Jul 16, 2025 | |
| MOH Molina Healthcare | Downgrades: Equal-Weight | $364 → $266 | $157.31 | +69.09% | 2 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $29.68 | -12.40% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $25 | $21.72 | +15.10% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $548 → $558 | $652.27 | -14.45% | 15 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $280.47 | +39.05% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $3.13 | +2.24% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $13 | $17.43 | -25.42% | 11 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $243 → $238 | $149.77 | +58.91% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $13.05 | +76.25% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $178.68 | -3.74% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $11.87 | -41.03% | 7 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $69 → $65 | $67.52 | -3.73% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $261.57 | +124.41% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $269.31 | +11.40% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $12.66 | +231.75% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $205.72 | +40.00% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | - | - | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $2.69 | +1,535.69% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $459.29 | -60.59% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $53.90 | -68.46% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $36.21 | +234.16% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $477.41 | +21.49% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $10.75 | +225.58% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $169.08 | +21.24% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $21.01 | -47.64% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $185.91 | -15.55% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $24.02 | +58.20% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $5.47 | +210.79% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $431.56 | -28.63% | 1 | Oct 25, 2017 |
Envista Holdings
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $20.89
Upside: -18.62%
CVS Health
Aug 1, 2025
Maintains: Overweight
Price Target: $80 → $82
Current: $65.51
Upside: +25.17%
Humana
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $290 → $277
Current: $274.94
Upside: +0.75%
Align Technology
Jul 31, 2025
Downgrades: Equal-Weight
Price Target: $249 → $154
Current: $140.49
Upside: +9.62%
Elevance Health
Jul 18, 2025
Maintains: Overweight
Price Target: $428 → $316
Current: $292.48
Upside: +8.04%
McKesson
Jul 16, 2025
Maintains: Overweight
Price Target: $770 → $810
Current: $659.01
Upside: +22.91%
Phillips 66
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $122 → $128
Current: $120.04
Upside: +6.63%
Cencora
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $289.15
Upside: +14.13%
Cardinal Health
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $146.30
Upside: +29.87%
Molina Healthcare
Jul 10, 2025
Downgrades: Equal-Weight
Price Target: $364 → $266
Current: $157.31
Upside: +69.09%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $29.68
Upside: -12.40%
May 9, 2025
Maintains: Overweight
Price Target: $20 → $25
Current: $21.72
Upside: +15.10%
May 5, 2025
Maintains: Overweight
Price Target: $548 → $558
Current: $652.27
Upside: -14.45%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $280.47
Upside: +39.05%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.13
Upside: +2.24%
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $17.43
Upside: -25.42%
Feb 14, 2025
Maintains: Overweight
Price Target: $243 → $238
Current: $149.77
Upside: +58.91%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $13.05
Upside: +76.25%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $178.68
Upside: -3.74%
Oct 11, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $11.87
Upside: -41.03%
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $67.52
Upside: -3.73%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $261.57
Upside: +124.41%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $269.31
Upside: +11.40%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $12.66
Upside: +231.75%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $205.72
Upside: +40.00%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: -
Upside: -
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $2.69
Upside: +1,535.69%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $459.29
Upside: -60.59%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $53.90
Upside: -68.46%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $36.21
Upside: +234.16%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $477.41
Upside: +21.49%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $10.75
Upside: +225.58%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $169.08
Upside: +21.24%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $21.01
Upside: -47.64%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $185.91
Upside: -15.55%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $24.02
Upside: +58.20%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $5.47
Upside: +210.79%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $431.56
Upside: -28.63%